GE to sell its biotech business for $21 billion to Danaher
February 25, 2019 at 08:20 AM EST
General Electric Co. agreed to sell its biotechnology business to Danaher Corp. for $21 billion in cash, moving to pay down debt by parting with one of its fastest growing businesses.
